Filtered By:
Source: Annals of Allergy, Asthma and Immunology
Infectious Disease: COVID-19

This page shows you your search results in order of date.

Order by Relevance | Date

Total 349 results found since Jan 2013.

Comprehensive care of adults with respiratory diseases must include vaccines
Vaccines are among the most effective tools we have to improve and save lives, but only if they are administered to eligible patients. In this issue, Naeger et al1 highlight the major opportunities that the health care community has to achieve high adult vaccination rates. These vaccines include those for prevention of coronavirus disease 2019 (COVID-19), pneumococcal, and influenza, diseases that respiratory health professionals are most aware of, plus pertussis (in Tdap), herpes zoster (HZ, shingles), and as of May 3, 2023, respiratory syncytial viral, for which adults with asthma and chronic obstructive pulmonary diseas...
Source: Annals of Allergy, Asthma and Immunology - September 1, 2023 Category: Allergy & Immunology Authors: Barbara P. Yawn, Dennis Williams, Gregory Poland Tags: Editorial Source Type: research

A qualitative investigation into vaccine hesitancy and confidence among people managing allergy
Vaccine hesitancy is multifactorial, and among atopic individuals, is exacerbated by documented, but rare, cases of allergic reactions to coronavirus disease 2019 (COVID-19) vaccines.1 –3 Furthermore, conflicting information regarding the safety of COVID-19 vaccines may have caused confusion among individuals with a history of severe allergies. We performed semistructured qualitative interviews to better understand how some adults and families managing allergy perceive vaccine m essaging and what influences their decisions to be vaccinated.
Source: Annals of Allergy, Asthma and Immunology - August 28, 2023 Category: Allergy & Immunology Authors: Ayel Luis R. Batac, Kaitlyn A. Merrill, Michael A. Golding, Elissa M. Abrams, Philippe B égin, Moshe Ben-Shoshan, Erika Ladouceur, Leslie E. Roos, Vladan Protudjer, Jennifer L.P. Protudjer Tags: Letters Source Type: research

A qualitative investigation into vaccine hesitancy and confidence amongst people managing allergy
Vaccine hesitancy has a multifactorial etiology, and, among atopic individuals, is exacerbated by documented, but rare, cases of allergic reactions to COVID-19 vaccines.1 –3 Furthermore, conflicting information regarding the safety of COVID-19 vaccines may have caused confusion among individuals with history of severe allergies. We performed semi-structured qualitative interviews to better understand how some adults and families managing allergy perceive vaccine me ssaging, and what influences their decisions to be vaccinated.
Source: Annals of Allergy, Asthma and Immunology - August 28, 2023 Category: Allergy & Immunology Authors: Ayel Luis R. Batac, Kaitlyn A. Merrill, Michael A. Golding, Elissa M. Abrams, Philippe B égin, Moshe Ben-Shoshan, Erika Ladouceur, Leslie E. Roos, Vladan Protudjer, Jennifer L.P. Protudjer Tags: Letters Source Type: research

Population-level trends in asthma and chronic obstructive pulmonary disease emergency department visits and hospitalizations before and during the coronavirus disease 2019 pandemic in the United States
Previous studies have identified reductions in exacerbations of chronic lung disease in many locales after onset of the coronavirus disease 2019 (COVID-19) pandemic.
Source: Annals of Allergy, Asthma and Immunology - August 22, 2023 Category: Allergy & Immunology Authors: Adam Gaffney, David U. Himmelstein, Steffie Woolhandler Source Type: research

Population-Level Trends in Asthma and COPD Emergency Department Visits and Hospitalizations Before and During the COVID-19 Pandemic in the US
Previous studies have identified reductions in exacerbations of chronic lung disease in many locales after onset of the COVID-19 pandemic.
Source: Annals of Allergy, Asthma and Immunology - August 22, 2023 Category: Allergy & Immunology Authors: Adam Gaffney, David U. Himmelstein, Steffie Woolhandler Tags: Original Article Source Type: research

Asthma in elderly and coronavirus disease 2019
Once the first wave of severe acute respiratory syndrome coronavirus 2 novel coronavirus disease subsided, the attempt was made to investigate both short- and long-term potential consequences, especially in high-risk patient cohorts including those after prolonged hospitalization and intensive therapy.1 Symptoms persisting 3 to 6 months after acute coronavirus disease 2019 (COVID-19) (post –COVID-19 syndrome) have been described.2-5 Currently, there is a lack of information on post–COVID-19 consequences in elderly patients with asthma.
Source: Annals of Allergy, Asthma and Immunology - August 7, 2023 Category: Allergy & Immunology Authors: Sergey N. Avdeev, Viliya V. Gaynitdinova, Anna A. Pozdnakova, Svetlana Yu Chikina, Karina A. Kosobokova Tags: Letters Source Type: research

Asthma in elderly and COVID-19: results of 90-day post-hospital follow-up
Once the first wave of SARS-CoV-2 novel coronavirus disease subsided, the attempt was made to investigate both short- and long-term potential consequences, especially in high-risk patient cohorts including those after prolonged hospitalization and intensive therapy1. Symptoms persisting 3 - 6 months after acute COVID-19 (post-COVID syndrome) have been described 2,3,4,5. Currently, there is a lack of information on post-COVID consequences in elderly patients with asthma. Asthma in elderly is known to have specific features, such as high comorbidity, use of multiple pharmacological agents, individual response to treatment, d...
Source: Annals of Allergy, Asthma and Immunology - August 7, 2023 Category: Allergy & Immunology Authors: Sergey N. Avdeev, Viliya V. Gaynitdinova, Anna A. Pozdnakova, Svetlana Yu Chikina, Karina A. Kosobokova Tags: Letters Source Type: research

Did the coronavirus disease 2019 pandemic change asthma prevalence?
Circulating coronaviruses have been associated with asthma exacerbations; however, early in the coronavirus disease 2019 pandemic, asthma exacerbations decreased.1 Similarly, other pandemic coronaviruses (sever acute respiratory syndrome [SARS] and Middle East Respiratory Syndrome) have not been associated with asthma exacerbations.2 However, as SARS coronavirus 2 (SARS-CoV-2) becomes less virulent and more like the circulating non-pandemic coronaviruses, there have been reports that asthma exacerbations are increasing.
Source: Annals of Allergy, Asthma and Immunology - August 1, 2023 Category: Allergy & Immunology Authors: Rebecca Koenigsberg, Mitchell H. Grayson Tags: Editorial Source Type: research

Preference for and impact of telehealth vs in-person asthma visits among Black and Latinx adults
Black and Latinx adults experience disproportionate asthma-related morbidity and limited specialty care access. The severe acute respiratory syndrome coronavirus 2 pandemic expanded telehealth use.
Source: Annals of Allergy, Asthma and Immunology - July 23, 2023 Category: Allergy & Immunology Authors: Israel C. Ugalde, Amanda Ratigan, Conner Merriman, Jing Cui, Brianna Ericson, Paula Busse, Jennifer K. Carroll, Thomas Casale, Juan Carlos Celed ón, Tamera Coyne-Beasley, Maureen Fagan, Anne L. Fuhlbrigge, Gabriela Gaona Villarreal, Paulina Arias Hernand Source Type: research

Intranasal steroid use and COVID-19 mortality among asthma and COPD patients: A retrospective cohort study
Systemic corticosteroids have been widely used for treating patients with severe acute respiratory distress syndrome. Inhaled corticosteroids may have a protective effect for treating acute COVID-19, however little is known about the potential effect of intranasal corticosteroids (INCS) on COVID-19 outcomes and severity.
Source: Annals of Allergy, Asthma and Immunology - July 4, 2023 Category: Allergy & Immunology Authors: Dr Virginia Hernandez Santiago, Dr Adeniyi Francis Fagbamigbe, Prof Frank Sullivan, Dr Utkarsh Agrawal, Dr Daniel Morales, Prof Colin McCowan, Prof Brian Lipworth Tags: Original Article Source Type: research

Intranasal steroid use and COVID-19 mortality among patients with asthma and COPD
Systemic corticosteroids have been widely used for treating patients with severe acute respiratory distress syndrome. Inhaled corticosteroids may have a protective effect for treating acute coronavirus disease 2019 (COVID-19); however, little is known about the potential effect of intranasal corticosteroids (INCS) on COVID-19 outcomes and severity.
Source: Annals of Allergy, Asthma and Immunology - July 4, 2023 Category: Allergy & Immunology Authors: Virginia Hernandez Santiago, Adeniyi Francis Fagbamigbe, Frank M Sullivan, Utkarsh Agrawal, Daniel Morales, Colin McCowan, Brian Lipworth Tags: Original Article Source Type: research

Controller therapy attenuates asthma exacerbations associated with prior severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children
Nearly 80% of asthma exacerbations are associated with viral respiratory infections.1 The first cases of coronavirus disease 2019 (COVID-19) because of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) started in late December 2019 in Wuhan, People's Republic of China, and was first reported in the United States in January 2020.2
Source: Annals of Allergy, Asthma and Immunology - June 12, 2023 Category: Allergy & Immunology Authors: Iris Kim, Tricia Morphew, Christine Chou, Louis Ehwerhemuepha, Stanley Galant Tags: Letters Source Type: research

Controller therapy attenuates asthma exacerbations associated with prior SARS-CoV-2 infection in children
Abbreviations: Coronavirus disease 2019 (COVID-19); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), angiotensin-converting enzyme 2 (ACE2), transmembrane serine protease 2 (TMPRSS2), inhaled corticosteroids (ICS), oral corticosteroid (OCS), short-acting beta-agonist (SABA), long-acting beta-agonist (LABA), leukotriene receptor antagonist (LTRA), rate ratios (RR), polymerase chain reaction (PCR)
Source: Annals of Allergy, Asthma and Immunology - June 12, 2023 Category: Allergy & Immunology Authors: Iris Kim, Tricia Morphew, Christine Chou, Louis Ehwerhemuepha, Stanley Galant Tags: Letters Source Type: research

Changes in the national prevalence of asthma and coronavirus disease 2019 fatality
The coronavirus disease 2019 (COVID-19) mitigation and containment strategies implemented by each country can influence the prevalence of asthma and its fatality.
Source: Annals of Allergy, Asthma and Immunology - May 2, 2023 Category: Allergy & Immunology Authors: Mart ín Bedolla-Barajas, Jaime Morales-Romero, Martín Robles-Figueroa, Tonatiuh Delgado-Figueroa Source Type: research

Changes in the national prevalence of asthma and COVID-19 fatality: A population-based cross-sectional study
: The COVID-19 mitigation and containment strategies implemented by each country can influence over the prevalence asthma and its fatality.
Source: Annals of Allergy, Asthma and Immunology - May 2, 2023 Category: Allergy & Immunology Authors: Mart ín Bedolla-Barajas, Jaime Morales-Romero, Martín Robles-Figueroa, Tonatiuh Delgado-Figueroa Source Type: research